Hamrick M W, Shi X, Zhang W, Pennington C, Thakore H, Haque M, Kang B, Isales C M, Fulzele S, Wenger K H
Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, GA 30912, USA.
Bone. 2007 Jun;40(6):1544-53. doi: 10.1016/j.bone.2007.02.012. Epub 2007 Feb 23.
Myostatin (GDF8) is a negative regulator of skeletal muscle growth and mice lacking myostatin show a significant increase in muscle mass and bone density compared to normal mice. In order to further define the role of myostatin in regulating bone mass we sought to determine if loss of myostatin function significantly altered the potential for osteogenic differentiation in bone marrow-derived mesenchymal stem cells in vitro and in vivo. We first examined expression of the myostatin receptor, the type IIB activin receptor (AcvrIIB), in bone marrow-derived mesenchymal stem cells (BMSCs) isolated from mouse long bones. This receptor was found to be expressed at high levels in BMSCs, and we were also able to detect AcvrIIB protein in BMSCs in situ using immunofluorescence. BMSCs isolated from myostatin-deficient mice showed increased osteogenic differentiation compared to wild-type mice; however, treatment of BMSCs from myostatin-deficient mice with recombinant myostatin did not attenuate the osteogenic differentiation of these cells. Loading of BMSCs in vitro increased the expression of osteogenic factors such as BMP-2 and IGF-1, but treatment of BMSCs with recombinant myostatin was found to decrease the expression of these factors. We investigated the effects of myostatin loss-of-function on the differentiation of BMSCs in vivo using hindlimb unloading (7-day tail suspension). Unloading caused a greater increase in marrow adipocyte number, and a greater decrease in osteoblast number, in myostatin-deficient mice than in normal mice. These data suggest that the increased osteogenic differentiation of BMSCs from mice lacking myostatin is load-dependent, and that myostatin may alter the mechanosensitivity of BMSCs by suppressing the expression of osteogenic factors during mechanical stimulation. Furthermore, although myostatin deficiency increases muscle mass and bone strength, it does not prevent muscle and bone catabolism with unloading.
肌肉生长抑制素(GDF8)是骨骼肌生长的负调节因子,与正常小鼠相比,缺乏肌肉生长抑制素的小鼠肌肉质量和骨密度显著增加。为了进一步明确肌肉生长抑制素在调节骨量中的作用,我们试图确定肌肉生长抑制素功能丧失是否会在体外和体内显著改变骨髓间充质干细胞的成骨分化潜能。我们首先检测了从小鼠长骨分离的骨髓间充质干细胞(BMSCs)中肌肉生长抑制素受体IIB型激活素受体(AcvrIIB)的表达。发现该受体在BMSCs中高水平表达,并且我们还能够使用免疫荧光在原位检测BMSCs中的AcvrIIB蛋白。与野生型小鼠相比,从缺乏肌肉生长抑制素的小鼠中分离的BMSCs表现出成骨分化增加;然而,用重组肌肉生长抑制素处理来自缺乏肌肉生长抑制素的小鼠的BMSCs并没有减弱这些细胞的成骨分化。体外加载BMSCs增加了成骨因子如BMP-2和IGF-1的表达,但发现用重组肌肉生长抑制素处理BMSCs会降低这些因子的表达。我们使用后肢卸载(7天尾悬吊)研究了肌肉生长抑制素功能丧失对体内BMSCs分化的影响。卸载导致缺乏肌肉生长抑制素的小鼠骨髓脂肪细胞数量增加幅度更大,成骨细胞数量减少幅度更大,比正常小鼠更明显。这些数据表明,来自缺乏肌肉生长抑制素的小鼠的BMSCs成骨分化增加是负荷依赖性的,并且肌肉生长抑制素可能通过在机械刺激期间抑制成骨因子的表达来改变BMSCs的机械敏感性。此外,虽然肌肉生长抑制素缺乏会增加肌肉质量和骨强度,但它并不能防止卸载引起的肌肉和骨分解代谢。